Senior Editor, Forbes
Matthew Herper tweeted...
View Matthew Herper's timeline and complete journalist profile →
RT @Loftus: My recent walkup to Merck's "Thrive" study of niacin-based drug, now failed $MRK ... http://t.co/8dfOus9w http://t.co/7mky5sHJ— Matthew Herper (@) December 20, 2012
Sign up to discover more journalists who cover and more.Create An Account
Share This Profile